18 mayo 2014

Yondelis US / Australia / Nueva Zelanda / SudAfrica / Brasil . Estimated Study Completion Date : July 2014 .

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma .

ClinicalTrials.gov processed this record on May 16, 2014 .

Health Authority:

United States: Food and Drug Administration .
Australia: Department of Health and Ageing Therapeutic Goods Administration .
New Zealand: Health Research Council .
South Africa: Medicines Control Council .
Brazil: Ministry of Health .

***********************************************

Study Start Date: June 2011
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)

***********************************************

Show 91 Study Locations
Sponsors and Collaborators
Janssen Research & Development, LLC
Pharma Mar, S.A.U.
Investigators

Study Director: Janssen Research & Development, LLC Clinical Trial Janssen Research & Development, LLC.